Efficacy of Axitinib After Nivolumab Failure in Metastatic Renal Cell Carcinoma

Background/Aim: Whether molecular-targeted therapy, particularly axitinib, is effective after failure of immune checkpoint inhibitors in metastatic renal cell carcinoma (mRCC) remains unclear. Here, we evaluated the therapeutic effect of axitinib as a third-line therapy following second-line nivolum...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:In Vivo
Main Authors: ISHIHARA, HIROKI, TAKAGI, TOSHIO, KONDO, TSUNENORI, FUKUDA, HIRONORI, TACHIBANA, HIDEKAZU, YOSHIDA, KAZUHIKO, IIZUKA, JUNPEI, OKUMI, MASAYOSHI, ISHIDA, HIDEKI, TANABE, KAZUNARI
Format: Artigo
Jezik:Inglês
Izdano: International Institute of Anticancer Research 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279840/
https://ncbi.nlm.nih.gov/pubmed/32354960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11943
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki